ABT’s 2Q13 sales in emerging markets grew 13%, year-over-year: http://finance.yahoo.com/news/abbott-reports-second-quarter-2013-114400548.html 2013 non-GAAP EPS guidance is unchanged at $1.98-2.04. Newly issued non-GAAP EPS guidance for 3Q13 is $0.51-0.53.